GlassScriptPhysician profile
Bryce Steven Lynn
NPI 1386938272
$8,704.01
in general payments reported to CMS, 2019-2025
19 companies · $1,563 in 2025
The $1,563 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,582 · 2020: $329 · 2021: $378 · 2022: $1,702 · 2023: $1,405 · 2024: $1,744 · 2025: $1,563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,711.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,013.77 | 2019-2025 | Synergy, General - Therapies, Watchman Access System |
| Abbott Laboratories | $1,636.49 | 2019-2025 | Dragonfly Opstar, Diamondback Coronary |
| Abiomed | $1,390.40 | 2022-2025 | Impella |
| Shockwave Medical, INC | $1,006.27 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $500.17 | 2022-2024 | Orsiro Mission, Pk Papyrus, Nhancer Rx |
| Angiodynamics, INC. | $386.53 | 2021-2024 | Angiovac |
| Philips North America LLC | $386.49 | 2019-2025 | (Bq9) Coronary Ivus, Coronary Other |
| Edwards Lifesciences Corporation | $303.23 | 2021-2023 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $222.29 | 2023-2025 | Onyx Frontier, Micra |
| Asahi Intecc USA, INC. | $199.61 | 2025 | Asahi Coronary Wires |
| Teleflex LLC | $165.45 | 2023 | Guideliner |
| Livanova USA, INC. | $142.57 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $117.11 | 2019 | |
| Janssen Pharmaceuticals, INC | $90.01 | 2019-2021 | |
| Medtronic Vascular, INC. | $81.64 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20.32 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.52 | 2024 | Eliquis |
| Amgen INC. | $13.23 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryce Lynn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.